Pharma Capital
Showing 40 of 40
Name Market Market Cap Share Price Daily Share Movement
abzena-logo.png Abzena plc AIM £51.69m £0.38 -1.32% ico_glass.png
Advanced-Oncotherapy-logo.png Advanced Oncotherapy AIM £20.71m £0.29 -8.06% ico_glass.png
akers.png Akers Biosciences, Inc. AIM £11.23m £1.55 31.91% ico_glass.png
allergytherap.gif Allergy Therapeutics plc AIM £142.43m £0.24 -2.54% ico_glass.png
Alliance-logo.png Alliance Pharma plc AIM £225.72m £0.48 2.69% ico_glass.png
amryt-pharma.jpg Amryt Pharmaceuticals AIM £44.27m £0.21 10.39% ico_glass.png
angle-logo.png ANGLE plc AIM £35.16m £0.47 1.08% ico_glass.png
avacta.png Avacta Group Plc AIM £42.74m £0.63 -0.79% ico_glass.png
c4x.png C4X Discovery Holdings plc AIM £34.03m £0.91 -0.55% ico_glass.png
clinigen-logo.png Clinigen Group PLC AIM £886.27m £7.70 1.58% ico_glass.png
collagen_solutions.png Collagen Solutions PLC AIM £14.63m £0.05 -2.63% ico_glass.png
concepta.png Concepta AIM £19.87m £0.18 6.62% ico_glass.png
constellation-logo.png Constellation Healthcare Technologies, Inc. AIM £- £- - ico_glass.png
deltex-logo.png Deltex Medical Group plc AIM £11.12m £0.04 0.00% ico_glass.png
E--therapeutics-logo.png e-Therapeutics plc AIM £22.82m £0.09 1.49% ico_glass.png
Ergomed-logo.png Ergomed Plc AIM £81.41m £2.01 2.29% ico_glass.png
fr.png Faron Pharmaceuticals Oy AIM £151.84m £5.48 0.00% ico_glass.png
FuturaMedical-Logo-1row-RGB.jpg Futura Medical plc. AIM £60.01m £0.50 -4.33% ico_glass.png
genedrive_logo.png Genedrive PLC AIM £7.94m £0.43 0.00% ico_glass.png
Horizon-logo.2.png Horizon Discovery Group PLC AIM £156.25m £1.63 0.00% ico_glass.png
imm.gif ImmuPharma PLC AIM £68.91m £0.52 0.97% ico_glass.png
MaxCyte.gif MaxCyte AIM £115.38m £2.65 -0.38% ico_glass.png
Midatech_pharma.png Midatech Pharma Plc AIM £40.92m £1.22 0.00% ico_glass.png
motif-bio-logo-2.png Motif Bio Plc AIM £48.48m £0.25 -1.00% ico_glass.png
nanobiotix_logo.png Nanobiotix SA EPA £- £- - ico_glass.png
netscientific-logo.png Netscientific PLC AIM £28.73m £0.56 0.00% ico_glass.png
optibiotix-logo-2.png OptiBiotix Health plc AIM £62.83m £0.80 1.91% ico_glass.png
redx-logo.png Redx Pharma Plc AIM £41.11m £0.33 -1.52% ico_glass.png
reneuron_logo.png ReNeuron Group Plc AIM £74.37m £0.02 0.00% ico_glass.png
rex_bionics_logo.png Rex Bionics PLC AIM £0.89m £0.04 0.00% ico_glass.png
sar.jpg Sareum Holdings Plc AIM £24.47m £0.01 0.00% ico_glass.png
scancell.gif Scancell Holdings Plc AIM £37.60m £0.14 0.00% ico_glass.png
silence-logo-2.jpg Silence Therapeutics plc AIM £61.69m £0.88 0.28% ico_glass.png
sphere_medical_sponsor_logo.gif Sphere Medical Holding PLC AIM £9.04m £0.06 6.25% ico_glass.png
summit_corp_logo.png Summit Therapeutics PLC AIM £127.58m £2.08 -2.35% ico_glass.png
synairgen-latest.jpg Synairgen plc AIM £27.41m £0.30 -2.44% ico_glass.png
tissue_regenix_sponsor_logo.png Tissue Regenix Group PLC AIM £117.82m £0.16 -1.59% ico_glass.png
Valirx-logo.png ValiRx Plc AIM £3.33m £0.03 0.00% ico_glass.png
Venn-life-logo.png Venn Life Sciences Holdings plc AIM £10.24m £0.17 0.00% ico_glass.png
WideCellsGroup-2.jpg WideCells Group LSE £6.62m £0.12 0.00% ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.